Pemetrexed 25 mg/mL Injection, Powder, Lyophilized, For Solution, 1 vial
by Hospira, Inc. · 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1060-01) / 4.2 mL in 1 VIAL, SINGLE-DOSE
NDC 00409-1060-01
🏷️ FDA NDC (as labeled)
0409-1060-01
billing pads the labeler segment with a zero
Rx only
Brand
Discontinued
Non-controlled
⚠ Discontinued by firm
🗂️ Data synced Mar 13, 2024 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jul 2025. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
🆔 Identity & classification
FDA NDC (as labeled)
0409-1060-01
Product NDC
0409-1060
11-digit billing NDC
00409106001
NCPDP billing unit
EA — each (per item)
Application #
NDA208746
Mechanism of action
Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through Jul 2025)
Route
INTRAVENOUS
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Substance
PEMETREXED TROMETHAMINE ANHYDROUS
GCN Seq No
083477
GCN
52463
HICL code
043305
Ingredient (HICL)
Pemetrexed
HIC1 code
V
Therapeutic class — broad (HIC1)
Neoplasms
HIC2 code
V1
Therapeutic class — intermediate (HIC2)
Antineoplastic Drugs
HIC3 code
V1B
Therapeutic class — specific (HIC3)
Antineoplastic - Antimetabolites
AHFS code
10:00.00.00
AHFS class
Antineoplastic Agents
FDB label name
PEMETREXED 100 MG VIAL
FDB brand name
Pemetrexed
Legend status
F — Federal legend — prescription drug or device
Why two NDCs?
The FDA registers this code as 0409-1060-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00409-1060-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerHospira, Inc.
Application holderHOSPIRA INC
FDA applicationNDA208746 (NDA)
Labeler code00409
Product typeHuman Prescription Drug
Portfolio317 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name PEMETREXED 100 MG VIAL Ingredient Pemetrexed
📗 Our plain-language guide HelloPharmacist
- Yes, they are absolutely necessary and not optional. The folic acid and vitamin B12 help protect your bone marrow and gut lining from the most severe side effects of pemetrexed — c...
- Why do I have to take vitamins and a steroid along with my chemo — are they really necessary?
- You need to be careful with ibuprofen. It can block one of the kidney transporters that your body uses to clear pemetrexed, which means pemetrexed can build up to higher levels and...
- Can I take ibuprofen or Advil while I'm on this treatment?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Pemetrexed — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Pemetrexed?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
| Medicare Part B allowsASP · J9323 | No ASP payment limit on file for J9323 this quarter. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🧾 Billing & reimbursement
FDA NDC (as labeled)0409-1060-01
11-digit billing NDC00409-1060-01
Format4-4-2 as registered → padded to 5-4-2 for billing (zero added to the labeler segment)
HCPCS J-codeJ9323
DescriptorINJECTION, PEMETREXED DITROMETHAMINE, 10 MG
Billing units / pkg10 units
Crosswalk sourcePDAC NDC-HCPCS crosswalk (DME MAC / DMEPOS)
Where does this data come from?
The HCPCS J-code crosswalk comes from the CMS ASP NDC-HCPCS crosswalk and the DMEPDAC (DME MAC) NDC-HCPCS crosswalk — free public CMS data. Billing units are derived from the code’s descriptor and the package amount.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Alimta 100 mg/4mL 00002-7640-01 | Eli | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 16729-0229-03 | Accord | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4.2mL 25021-0260-10 | Sagent | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 31722-0336-31 | Camber | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg 43547-0632-01 | Solco | 100 injections | — | AP | FDA listed | — |
| Pemetrexed disodium 100 mg/4mL 43598-0386-62 | Dr. | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 55150-0381-01 | Eugia | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 63323-0134-10 | Fresenius | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 67184-0503-01 | Qilu | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 68001-0535-41 | BluePoint | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 68001-0538-41 | BluePoint | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 68001-0543-41 | BluePoint | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4mL 70069-0834-01 | Somerset | 1 vial | — | AP | FDA listed | — |
| pemetrexed 100 mg/4mL 70710-1654-01 | Zydus | 1 vial | — | AP | FDA listed | — |
| pemetrexed 100 mg/4mL 70771-1691-01 | Zydus | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/4.2mL 71288-0145-10 | Meitheal | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/10mL 71288-0166-10 | Meitheal | 1 vial | — | AP | Discontinued | — |
| Pemetrexed 100 mg/4mL 72338-0100-01 | Waverley | 1 vial | — | AP | FDA listed | — |
| Pemetrexed 100 mg/10mL 72603-0325-01 | NorthStar | 1 vial | — | AP | FDA listed | — |
| Pemetrexed Dipotassium 100 mg/4mL 83831-0111-01 | Avyxa | 1 vial | — | — | FDA listed | — |
| Axtle 100 mg/4mL 83831-0131-01 | Avyxa | 1 vial | — | — | FDA listed | — |
| Pemetrexed 25 mg/mLthis 00409-1060-01 | Hospira, | 1 vial | — | — | Discontinued | — |
About this product: this is the brand-name version. Some generic versions are approved by the FDA, but we could not confirm current pharmacy availability from our pricing/market data.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed
The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Pemetrexed — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Pemetrexed. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$15.9K
Claims incl. refills
11
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$1,441.77
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pemetrexed — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 59%
Female · 41%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00409-1060-01 You're viewing this | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1060-01) / 4.2 mL in 1 VIAL, SINGLE-DOSE | 2022-06-20 | Discontinued by firm |
🧭 About this NDC listing & data coverage
Finished prescription product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | ✓ Available |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Why is there no full label on this page?
No structured FDA label (SPL) is currently linked to this NDC in DailyMed/openFDA. That can happen with older listings, certain OTC and repackaged products, and recently updated listings whose label has not yet propagated. The listing itself is still valid — this page shows everything the public feeds provide for this package.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0409-1060-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00409-1060-01, written without dashes as 00409106001. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00409-1060-01, the first segment (00409) is the labeler code FDA assigned to Hospira, Inc.; the middle segment (1060) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Who lists this product with the FDA?
Hospira, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
Does this product have a billing J-code?
Yes — this NDC cross-references HCPCS code J9323 for medical-claim billing (typically used when a product is administered in a clinical setting rather than dispensed at a retail pharmacy). See the Billing section on this page.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.